Allogene Therapeutics Inc.
ALLO | NASDAQ
$1.71
+$0.02 (+1.18%)
Sep 22, 2026, 1:29 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.57 | -1.61 | -1.54 | -2.64 | -11.13 | -12.13 |
PEG Ratio | 0.05 | 0.04 | 0.13 | -0.03 | 0.31 | -0.89 |
PS Ratio | n/a | 18.86K | 5.3K | 5.77K | 17.76 | n/a |
PB Ratio | 1.03 | 0.98 | 0.98 | 1.35 | 2.19 | 2.81 |
P/FCF Ratio | -2.02 | -2.06 | -2.11 | -3.99 | -9.82 | -16.78 |
P/OCF Ratio | -2.03 | -2.07 | -2.12 | -4.08 | -10.96 | -26.40 |
OCF/S Ratio | n/a | -910.45K | -250.25K | -141.36K | -161.99 | n/a |
Debt / Equity Ratio | 0.28 | 0.21 | 0.19 | 0.15 | 0.08 | 0.05 |
Quick Ratio | 7.93 | 8.54 | 12.38 | 9.84 | 9.84 | 8.96 |
Current Ratio | 7.93 | 8.54 | 12.38 | 9.84 | 9.84 | 8.96 |
Asset Turnover | n/a | 0 | 0 | 0 | 0.11 | n/a |
Interest Coverage | -192.50 | -1.51K | n/a | n/a | n/a | n/a |
Return on Equity | -65.25% | -61.01% | -63.89% | -51.05% | -19.68% | -23.18% |
Return on Assets | -45.90% | -46.94% | -50.91% | -41.43% | -17.32% | -20.38% |
Return on Invested Capital | -52.84% | -52.47% | -53.51% | -43.36% | -17.91% | -22.72% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 100% | 100% | -9.06K% | 100% | n/a |
Net Profit Margin | n/a | -1.17M% | -344.49K% | -218.21K% | -159.57% | n/a |
Pretax Profit Margin | n/a | -1.17M% | -344.49K% | -218.21K% | -159.57% | n/a |
Operating Profit Margin | n/a | -1.24M% | -344.99K% | -215.09K% | -157.94% | n/a |
FCF Margin | n/a | -913.61K% | -251.84K% | -144.69K% | -180.79% | n/a |
EBITDA Margin | n/a | -1.11M% | -329.54K% | -209.05K% | -150.41% | n/a |
Add to Watchlist
Select watchlists to add or remove ALLO